logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Tonsillitis

    FiltersReset Filters
    6 results

    • azithromycin

      (Azithromycin)
      Bionpharma Inc.
      Usage: Azithromycin tablets are indicated for treating mild to moderate infections from susceptible bacteria, including acute bacterial exacerbations of chronic bronchitis, sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, uncomplicated skin infections, urethritis/cervicitis, and genital ulcer disease. Dosages vary between adults and pediatric patients.

    • cefaclor

      (cefaclor)
      Azorian Pharma, LLC
      Usage: Cefaclor is indicated for treating infections such as otitis media, lower respiratory tract infections, pharyngitis, tonsillitis, urinary tract infections, and skin infections caused by susceptible bacteria, including *Streptococcus pneumoniae*, *Haemophilus influenzae*, *Streptococcus pyogenes*, and others. Proper culture and susceptibility testing is recommended.

    • cefadroxil

      (Cefadroxil)
      Lupin Pharmaceuticals Inc
      Usage: Cefadroxil for oral suspension is indicated for treating urinary tract infections, skin and skin structure infections, and pharyngitis/tonsillitis caused by specific bacteria, including E. coli, staphylococci, and Streptococcus pyogenes. It should be used based on culture results to prevent antibiotic resistance.

    • cefadroxil

      (Cefadroxil)
      NorthStar RxLLC
      Usage: Cefadroxil is indicated for treating infections caused by susceptible organisms, including urinary tract infections, skin and skin structure infections, and pharyngitis/tonsillitis due to Group A streptococci. It aims to reduce drug-resistant bacteria and should only be used when infections are proven or suspected to be bacterial.

    • cefprozil

      (Cefprozil)
      Ascend Laboratories, LLC
      Usage: Cefprozil is indicated for mild to moderate infections caused by specific bacteria, including pharyngitis/tonsillitis, otitis media, acute sinusitis, acute bacterial exacerbation of chronic bronchitis, and uncomplicated skin infections. It should be used selectively to prevent drug-resistant bacteria development.

    • cefprozil

      (Cefprozil)
      Aurobindo Pharma Limited
      Usage: Cefprozil is indicated for treating mild to moderate infections caused by susceptible bacteria, including pharyngitis, otitis media, acute sinusitis, acute bacterial exacerbation of chronic bronchitis, and uncomplicated skin infections. It should be used judiciously to prevent drug-resistant bacteria development.